Nordea Investment Management
GNMK

Nordea Investment Management’s GenMark Diagnostics, Inc GNMK Stock Holding History

Nordea Investment Management’s Portfolio GNMK Stock Details GNMK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-26,246
Closed -$629K – 1012
2021
Q1 		$629K Buy
+26,246
New +$488K ﹤0.01% 863

Nordea Investment Management's GNMK Position: Q2 2021 in Review

Nordea Investment Management sold out of GenMark Diagnostics, Inc (GNMK) in Q2 2021, closing a stake of 26,246 shares — an estimated $629K sold.

Nordea Investment Management first reported a position in GNMK in Q1 2021 and held it in 1 quarter. The position peaked at $629K in Q1 2021. 0 funds tracked by Wall St. Rank hold GNMK as of Q2 2021.

  • Nordea Investment Management reported no remaining GenMark Diagnostics, Inc position as of Q2 2021 after selling out during the quarter.
  • Nordea Investment Management sold 26,246 GenMark Diagnostics, Inc shares in Q2 2021, an estimated $629K.
  • Nordea Investment Management first reported a position in GenMark Diagnostics, Inc in Q1 2021 and held it in 1 quarter.
  • Nordea Investment Management's GenMark Diagnostics, Inc position peaked at $629K in Q1 2021.
  • 0 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q2 2021.

Based on Nordea Investment Management's 13F filing for Q2 2021, filed 16 Jul 2021.